These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 24741596

  • 1. Anti-nuclear antibodies in daily clinical practice: prevalence in primary, secondary, and tertiary care.
    Avery TY, van de Cruys M, Austen J, Stals F, Damoiseaux JG.
    J Immunol Res; 2014; 2014():401739. PubMed ID: 24741596
    [Abstract] [Full Text] [Related]

  • 2. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.
    Bonroy C, Schouwers S, Berth M, Stubbe M, Piette Y, Hoffman I, Devreese K, Van Hoovels L.
    Clin Chem Lab Med; 2018 Jun 27; 56(7):1090-1099. PubMed ID: 29427547
    [Abstract] [Full Text] [Related]

  • 3. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
    Lundgren MC, Sapkota S, Peterson DJ, Crosson JT.
    J Immunol Methods; 2021 Jan 27; 488():112904. PubMed ID: 33121975
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z, Ren Y, Liu D, Lin F, Liang Y.
    APMIS; 2016 Sep 27; 124(9):805-11. PubMed ID: 27328803
    [Abstract] [Full Text] [Related]

  • 5. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
    Broadfoot A, Sivertsen T, Baumgart K.
    Pathology; 2016 Apr 27; 48(3):247-50. PubMed ID: 27020500
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.
    González Rodríguez C, Fuentes Cantero S, Pérez Pérez A, Vázquez Barbero FJ, León Justel A.
    J Clin Lab Anal; 2021 Sep 27; 35(9):e23914. PubMed ID: 34347308
    [Abstract] [Full Text] [Related]

  • 7. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort.
    Miyara M, Albesa R, Charuel JL, El Amri M, Fritzler MJ, Ghillani-Dalbin P, Amoura Z, Musset L, Mahler M.
    Clin Dev Immunol; 2013 Sep 27; 2013():703759. PubMed ID: 23476678
    [Abstract] [Full Text] [Related]

  • 8. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
    Yumuk Z, Demir M.
    J Immunol Methods; 2020 May 27; 480():112754. PubMed ID: 32057435
    [Abstract] [Full Text] [Related]

  • 9. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases].
    Duran A, Çetin Duran A, Taşkıran İ.
    Mikrobiyol Bul; 2022 Jan 27; 56(1):81-94. PubMed ID: 35088962
    [Abstract] [Full Text] [Related]

  • 10. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
    Seelig CA, Bauer O, Seelig HP.
    Clin Lab; 2016 Jan 27; 62(4):499-517. PubMed ID: 27215068
    [Abstract] [Full Text] [Related]

  • 11. High Sensitivity Detection of Anti-DFS70 Antibodies by Radioimmunoprecipitation Assay (RIPA).
    Seelig CA, Blüthner M, Seelig HP.
    Clin Lab; 2020 May 01; 66(5):. PubMed ID: 32390377
    [Abstract] [Full Text] [Related]

  • 12. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA, Bast EJ, Derksen RH.
    Rheumatology (Oxford); 2006 May 01; 45(5):629-35. PubMed ID: 16368728
    [Abstract] [Full Text] [Related]

  • 13. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
    La Jeon Y, Kang SY, Lee WI, Kim MH.
    Ann Clin Lab Sci; 2019 Sep 01; 49(4):496-502. PubMed ID: 31471339
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases.
    Shovman O, Gilburd B, Chayat C, Amital H, Langevitz P, Watad A, Guy A, Perez D, Azoulay D, Blank M, Segal Y, Bentow C, Mahler M, Shoenfeld Y.
    Clin Exp Rheumatol; 2018 Sep 01; 36(1):121-126. PubMed ID: 28770702
    [Abstract] [Full Text] [Related]

  • 15. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
    Tipu HN, Bashir MM.
    J Coll Physicians Surg Pak; 2018 Jan 01; 28(1):40-43. PubMed ID: 29290190
    [Abstract] [Full Text] [Related]

  • 16. A novel magnetic bead-based immunoprecipitation method for anti-dense fine speckled 70 antibodies.
    Chen R, Wei X, Yang C, Nguyen K.
    Pathology; 2023 Oct 01; 55(6):843-849. PubMed ID: 37336684
    [Abstract] [Full Text] [Related]

  • 17. Clinical use of anti-DFS70 autoantibodies.
    Kang SY, Lee WI, Kim MH, La Jeon Y.
    Rheumatol Int; 2019 Aug 01; 39(8):1423-1429. PubMed ID: 30972541
    [Abstract] [Full Text] [Related]

  • 18. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.
    Mahler M, Hanly JG, Fritzler MJ.
    Autoimmun Rev; 2012 Jul 01; 11(9):642-5. PubMed ID: 22100330
    [Abstract] [Full Text] [Related]

  • 19. The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases.
    Mahler M, Fritzler MJ.
    Clin Dev Immunol; 2012 Jul 01; 2012():494356. PubMed ID: 23304189
    [Abstract] [Full Text] [Related]

  • 20. Antinuclear antibody titration and pattern are helpful in the diagnosis of systemic autoimmune rheumatic diseases.
    Mohd Razi MS, Sugumaran Y, Mohd Haniz NA, Khilmie K, Osmera AH, Jauhary EJ, Wahab AA.
    Malays J Pathol; 2024 Apr 01; 46(1):63-69. PubMed ID: 38682845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.